JNJ dividend yield: 3.36%. ABBV dividend yield: 3.67%. Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices. AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.
Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.
Is JNJ or ABBV better for dividend income in 2026?
JNJ currently offers a 3.36% yield (4.96/share/year) while ABBV offers 3.67% (6.20/share/year). ABBV provides higher current income. However, ABBV has grown its dividend faster (8.9% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in JNJ vs ABBV earn per year?
With $10,000 invested today: JNJ pays approximately $336/year. ABBV pays approximately $367/year. With DRIP reinvestment over 10 years, these grow to $828/year (JNJ) and $1,154/year (ABBV).
Does JNJ or ABBV pay monthly dividends?
JNJ pays quarterly dividends. ABBV pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this JNJ vs ABBV comparison by email
Save your analysis + get weekly dividend insights. Free forever.